US EditionDaily Aspirin Not Reliable for Preventing Bowel Cancer
Aspirin shows no significant colorectal cancer prevention within 5–15 years and increases bleeding risk, based on 10 trials with 124,837 participants, Cochrane researchers say.
7 Articles
7 Articles
Some hoped for aspirin & co. as a simple means of protecting them from colon cancer.A large study from China shows that this hope does not seem to be fulfilled.Take daily aspirin and thus reduce the risk of colon cancer? Chinese researchers clearly oppose it in the journal "Cochrane Database of Systematic Reviews" – after systematically evaluating patient data from clinical studies.
Daily aspirin does not lower risk, experts say - Health Care Today
Colorectal, or bowel, cancer is the third most common cancer worldwide, making up 10% of cancer diagnoses. It most commonly affects people over the age of 50, but cases in younger people are increasing. Studies have found that in people with a genetic risk, such as Lynch syndrome, daily aspirin can cut their risk of colorectal cancer. However, a new review has found that, for the general population, daily aspirin appears to offer no protection a…
Colon cancer, also known as colorectal cancer, is one of the most common types of cancer in the world. Its prevention usually includes maintaining a healthy lifestyle and regular screening tests. In recent years, the role of over-the-counter drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs), including ibuprofen and aspirin, has also been investigated in reducing the incidence of colon cancer. NSAIDs are often used to reduce inflammat…
Aspirin Shows Limited Immediate Effect in Bowel Cancer Prevention
Aspirin, a widely accessible medication known for its anti-inflammatory and analgesic properties, has long been hypothesized as a potential agent for cancer prevention, particularly colorectal cancer. Despite enthusiasm sparked by earlier studies suggesting a reduction in colorectal cancer incidence with regular aspirin use, a recent comprehensive Cochrane systematic review has brought this assumption into question. Conducted by researchers at t…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
